Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Envigo collaboration with OCSiAl and Intertek results in single wall carbon nanotubes completing REACH registration for the first time ever - The Pharma Times | Pharma & Health Care News Portal
Categories: Latest

Envigo collaboration with OCSiAl and Intertek results in single wall carbon nanotubes completing REACH registration for the first time ever

New Delhi, October 15, 2016: Envigo is pleased to announce the successful outcome of its industry collaboration with Intertek and OCSiAl to meet the latter’s regulatory requirements for its core product: TUBALL™ single wall carbon nanotubes. As a result of the collaboration, OCSiAl has opened a new substance in the EU’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation under the number 01-2120130006-75-0000. This registration proves that TUBALL™ single wall carbon nanotubes fully comply with REACH regulations. OCSiAl is the world’s first manufacturer of single wall carbon nanotubes (SWCNT) to complete REACH registration, taking the lead in raising the visibility of nanotube management worldwide and boosting its applications in a wide range of industries.

Over the course of six months, scientists at OCSiAl, Envigo and Intertek collaborated to conduct extensive research and testing on potentially hazardous properties of SWCNT. These efforts resulted in a technical and highly detailed analysis of SWCNT, their nature and potential risks, as well as in specifications on particular methods of risk management. This in-depth information will support the expansion of mass applications of SWCNT in various industries, including consumable products.

OCSiAl is the only company in the market that is capable of producing industrial-scale volumes of single wall carbon nanotubes. With its REACH registration, OCSiAl currently commercializes 10 tonnes of single wall carbon nanotubes in Europe. OCSiAl’s global production capacity of TUBALL™ will reach 60 tonnes next year. REACH registration will support OCSiAl’s drive to further scale up its nanotube manufacturing volumes and boost the company’s presence in the European market.

Adrian Hardy, Chief Executive Officer of Envigo, comments about the successful registration of OCSiAl’s product: “It’s very exciting for Envigo to be a partner in fostering important innovation – in this instance bringing our skills, expertise and comprehensive REACH testing capabilities to help OCSiAl meet all of the REACH requirements for its TUBALL™ product. We are therefore delighted to have worked closely with Intertek and OCSiAl to enable the REACH registration of single wall carbon nanotubes – an industry first.”

According to OCSiAl’s EHS Lead Manager, Gunther Van Kerckhove, “OCSiAl shares REACH’s goals and considers the completion of mandatory registration as one of the milestones in the company’s goal to provide the European market and global community with a more comprehensive understanding of nanotubes, their nature, safety, and potential for use in a wide range of industries and products.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

21 hours ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

2 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

3 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

6 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420